company background image
4556 logo

KAINOS Laboratories TSE:4556 Stock Report

Last Price

JP¥1.24k

Market Cap

JP¥5.5b

7D

2.5%

1Y

17.6%

Updated

26 Mar, 2024

Data

Company Financials

KAINOS Laboratories, Inc.

TSE:4556 Stock Report

Market Cap: JP¥5.5b

4556 Stock Overview

KAINOS Laboratories, Inc. engages in the development, manufacture, marketing, distribution, and import/export of pharmaceuticals, diagnostic reagents, and related chemical products in Japan.

4556 fundamental analysis
Snowflake Score
Valuation0/6
Future Growth0/6
Past Performance0/6
Financial Health0/6
Dividends0/6

KAINOS Laboratories, Inc. Competitors

Price History & Performance

Summary of all time highs, changes and price drops for KAINOS Laboratories
Historical stock prices
Current Share PriceJP¥1,235.00
52 Week HighJP¥1,289.00
52 Week LowJP¥1,000.00
Beta0
1 Month Change7.11%
3 Month Change13.93%
1 Year Change17.62%
3 Year Change20.61%
5 Year Change29.32%
Change since IPO12.27%

Recent News & Updates

Recent updates

Shareholder Returns

4556JP Medical EquipmentJP Market
7D2.5%-2.4%2.0%
1Y17.6%24.0%38.8%

Return vs Industry: 4556 underperformed the JP Medical Equipment industry which returned 24% over the past year.

Return vs Market: 4556 underperformed the JP Market which returned 38.8% over the past year.

Price Volatility

Is 4556's price volatile compared to industry and market?
4556 volatility
4556 Average Weekly Movement3.1%
Medical Equipment Industry Average Movement3.9%
Market Average Movement3.9%
10% most volatile stocks in JP Market8.3%
10% least volatile stocks in JP Market2.1%

Stable Share Price: 4556 has not had significant price volatility in the past 3 months.

Volatility Over Time: 4556's weekly volatility (3%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
1975n/aYukihiro Nagatsuhttps://www.kainos.co.jp

KAINOS Laboratories, Inc. engages in the development, manufacture, marketing, distribution, and import/export of pharmaceuticals, diagnostic reagents, and related chemical products in Japan. It is also involved in the development, manufacture, marketing, distribution, and import/export of physical and chemical measurement instruments, and medical supplies, as well as nutrition supplements, foodstuff, animal feed, and related products. The company offers various biochemical clinical testing reagents systems, such as Aqua-auto Kainos CRE-IV Test Kit, a liquid form creatinine measurement reagent kit for various makes of automatic analyzer systems; Aqua-auto Kainos ALB Test Kit, a liquid form reagent kit; and Aqua-auto Kainos UN-II Test Kit, a liquid urea nitrogen measurement reagent kit.

KAINOS Laboratories, Inc. Fundamentals Summary

How do KAINOS Laboratories's earnings and revenue compare to its market cap?
4556 fundamental statistics
Market capJP¥5.51b
Earnings (TTM)JP¥82.76m
Revenue (TTM)JP¥4.44b

0.0x

P/E Ratio

0.0x

P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
4556 income statement (TTM)
RevenueJP¥4.44b
Cost of RevenueJP¥2.89b
Gross ProfitJP¥1.55b
Other ExpensesJP¥1.47b
EarningsJP¥82.76m

Last Reported Earnings

Dec 31, 2010

Next Earnings Date

n/a

Earnings per share (EPS)0
Gross Margin0.00%
Net Profit Margin0.00%
Debt/Equity Ratio0.0%

How did 4556 perform over the long term?

See historical performance and comparison
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.